Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin open-label extension for painful diabetic peripheral neuropathy
NCT00553280Phase 3Completed
- Sponsor
- Viatris
- Start
- Feb 2008
- Primary completion
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of pregabalin in diabetic peripheral neuropathy (DPN), sponsored by Viatris. Started Feb 2008; status: completed.
02
Drugs
pregabalin
03
Conditions
diabetic peripheral neuropathy (DPN)
Beyond the preview
Go deeper on NCT00553280.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00553280.